Zobrazeno 1 - 10 of 1 006 pro vyhledávání: '"A, Cattina"'
2
Akademický článek
Comparison of first-line treatment with bendamustine plus rituximab versus R-CHOP for patients with follicular lymphoma grade 3A: Results of a retrospective study from the Fondazione Italiana Linfomi
Autor: Gloria Margiotta-Casaluci, Sara Bigliardi, Federica Cocito, Erika Meli, Luigi Petrucci, Maura Nicolosi, Ombretta Annibali, Carola Boccomini, Valentina Bozzoli, Alessia Castellino, Federica Cattina, Natalia Cenfra, Sabino Ciavarella, Sofya Kovalchuk, Francesco Rotondo, Angelo Fama, Jacopo Olivieri, Francesco Zaja
Publikováno v: Frontiers in Oncology, Vol 13 (2023)
In the setting of follicular lymphoma (FL), frontline therapy with rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHOP) has represented for many years the standard of care for patients with symptomatic advanced disease. More recently, th
Externí odkaz: https://doaj.org/article/3b227feed7e9451ba1763b7a2727dde7
Zobrazit plný text záznamu
3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
4
Akademický článek
Case Report: Late Onset of Myelodysplastic Syndrome From Donor Progenitor Cells After Allogeneic Stem Cell Transplantation. Which Lessons Can We Draw From the Reported Case?
Autor: Mirko Farina, Simona Bernardi, Lisa Gandolfi, Camilla Zanaglio, Enrico Morello, Alessandro Turra, Tatiana Zollner, Doriana Gramegna, Benedetta Rambaldi, Federica Cattina, Nicola Polverelli, Michele Malagola, Domenico Russo
Publikováno v: Frontiers in Oncology, Vol 10 (2020)
BackgroundMyelodysplastic syndromes and acute leukemias after allogeneic stem cell transplantation (allo-SCT) are mainly caused by recurrence of the primitive leukemic clones. More rarely, they originate from donor hematopoietic stem cells, developin
Externí odkaz: https://doaj.org/article/68659f4ccd2f4d73a6f1d2fc8e4586c8
Zobrazit plný text záznamu
5
Akademický článek
ETV6: A Candidate Gene for Predisposition to 'Blend Pedigrees'? A Case Report from the NEXT-Famly Clinical Trial
Autor: Simona Bernardi, Mirko Farina, Camilla Zanaglio, Federica Cattina, Nicola Polverelli, Francesca Schieppati, Federica Re, Chiara Foroni, Michele Malagola, Andrew J. Dunbar, Domenico Russo
Publikováno v: Case Reports in Hematology, Vol 2020 (2020)
Background. The identification of germline mutations in familial leukemia predisposition genes by next generation sequencing is of pivotal importance. Lately, some “blend pedigrees” characterized by both solid and hematologic malignancies have be
Externí odkaz: https://doaj.org/article/9694ff2866e74afa9e85776dd8e0f21c
Zobrazit plný text záznamu
6
Akademický článek
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS.
Autor: Michele Malagola, Raffaella Greco, Stella Santarone, Anna Paola Iori, Luisa Quatrocchi, Walter Barberi, Bruzzese Antonella, Salvatore Leotta, Alessandra Carotti, Antonio Pierini, Simon Bernardi, Enrico Morello, Nicola Polverelli, Alessandro Turra, Federica Cattina, Lisa Gandolfi, Benedetta Rambaldi, Francesca Lorentino, Francesca Serio, Annalisa Natale, Giuseppe Milone, Andrea Velardi, Robin Foà, Fabio Ciceri, Domenico Russo, Jacopo Peccatori
Publikováno v: Mediterranean Journal of Hematology and Infectious Diseases, Vol 11, Iss 1 (2019)
CMV represents one of the most serious life-threatening complications of allogeneic stem cell transplantaion (allo-SCT). Pre-emptive treatment is highly effective, but toxicity and repetitive reactivation of CMV represent a major challenge in the cli
Externí odkaz: https://doaj.org/article/c4fd363ce2034b43895bbe1d73b80d6d
Zobrazit plný text záznamu
7
Akademický článek
Biological versus Clinical Risk Factors in Acute Myeloid Leukemia: Is There a Winner?
Autor: M. Malagola, N. Polverelli, V. Cancelli, E. Morello, A. Turra, E. Borlenghi, F. Cattina, B. Rambaldi, S. Bernardi, C. Zanaglio, Elif Dereli Eke, L. Gandolfi, M. Farina, D. Russo
Publikováno v: Case Reports in Hematology, Vol 2019 (2019)
We present a case of a patient with a three-month history of peripheral blood cytopenia without a confirmed diagnosis of myelodysplastic syndrome, who developed a favourable-risk acute myeloid leukemia (AML), according to the European Leukemia Net (E
Externí odkaz: https://doaj.org/article/382c0d489cd9414f8b51a0a43665bb6c
Zobrazit plný text záznamu
8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje